Caregivers of patients receiving long-term treatment with a tyrosine kinase inhibitor (TKI) for gastrointestinal stromal tumour (GIST): a cross-sectional assessment of their distress and burden

Gastrointestinal Cancer

EPIGIST: An observational real-life study on patients with metastatic gastrointestinal stromal tumors receiving imatinib

PLoS One.

Bouché O, Cesne AL, Rios M, Chaigneau L, Italiano A, Duffaud F, Lecomte T, Arsène D, Manfredi S, Aparicio T, Remy S, Isambert N, Collard O, Priou F, Bertucci F, Sambuc R, Bisot-Locard S, Bourges O, Chabaud S, Blay JY

doi: 10.1371/journal.pone.0204117.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Long-term treatment with plecanatide was safe and tolerable in patients with irritable bowel syndrome with constipation

Curr Med Res Opin.

Barish CF, Crozier RA, Griffin P

doi: 10.1080/03007995.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Irritable Bowel Syndrome (IBS) and Chronic Constipation Long-term treatment with plecanatide was safe and tolerable in patients with irritable bowel syndrome with constipation

Curr Med Res Opin.

Barish CF, Crozier RA, Griffin P

doi: 10.1080/03007995.

Gastrointestinal Cancer

Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors following progression with imatinib, sunitinib and regorafenib

Ther Adv Med Oncol.

Vincenzi B, Nannini M, Badalamenti G, Grignani G, Fumagalli E, Gasperoni S, D'Ambrosio L, Incorvaia L, Stellato M, Spalato Ceruso M, Napolitano A, Valeri S, Santini D, Tonini G, Casali PG, Dei Tos AP, Pantaleo MA

doi: 10.1177/

Gastrointestinal Cancer

Gastrointestinal bleeding in patients with pancreatic cancer: Causes and haemostatic treatments

United European Gastroenterol J.

Aguilera Munoz L, de Mestier L, Lamallem H, Jaïs B, Maire F, Lévy P, Rebours V, Hammel P

doi: 10.1177/2050640620939788.

Further Publications

On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites

J Hepatol

Caraceni P, Tufoni M, Zaccherini G, Riggio O, Angeli P, Alessandria C, Neri S, Foschi FG, Levantesi F, Airoldi A, Simone L, Svegliati-Baroni G, Fagiuoli S, Laffi G, Cozzolongo R, Di Marco V, Sangiovanni V, Morisco F, Toniutto P, Gasbarrini A, De Marco R, Piano S, Nardelli S, Elia C, Roncadori A, Baldassarre M, Bernardi M, ANSWER Study Investigators.

doi: 10.1016/j.jhep.2020.08.021

Inflammatory Bowel Disease

Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn's Disease: Results from the Phase 2 Open-Label Extension Study

J Crohns Colitis

Ferrante M, Feagan BG, Panés J, Baert F, Louis E, Dewit O, Kaser A, Duan WR, Pang Y, Lee WJ, Gustafson D, Liao X, Wallace K, Kalabic J, D'Haens GR

doi: 10.1093/ecco-jcc/jjab093

Gastrointestinal Cancer

Clinical activity of ripretinib in patients with advanced gastrointestinal stromal tumor harboring heterogenous KIT/PDGFRA mutations in the phase 3 INVICTUS study

Clin Cancer Res

Bauer S, Heinrich MC, George S, Zalcberg JR, Serrano C, Gelderblom H, Jones RL, Attia S, D'Amato G, Chi P, Reichardt P, Meade J, Su Y, Ruiz-Soto R, Blay JY, von Mehren M, Schöffski P

doi: 10.1158/1078-0432.CCR-21-1864

Inflammatory Bowel Disease

Short and long-term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry

Aliment Pharmacol Ther.

Chaparro M, Garre A, Ricart E, Iborra M, Mesonero F, Vera I, Riestra S, García-Sánchez V, Luisa De Castro M, Martin-Cardona A, Aldeguer X, Mínguez M, de-Acosta MB, Rivero M, Muñoz F, Andreu M, Bargalló A, González-Muñoza C, Pérez Calle JL, García-Sepulcre MF, Bermejo F, Huguet JM, Cabriada JL, Gutiérrez A, Mañosa M, Villoria A, Carbajo AY, Lorente R, García-López S, Piqueras M, Hinojosa E, Arajol C, Sicilia B, Conesa AM, Sainz E, Almela P, Llaó J, Roncero O, Camo P, Taxonera C, Domselaar MV, Pajares R, Legido J, Madrigal R, Lucendo AJ, Alcaín G, Doménech E, Gisbert JP; GETECCU study group

doi: 10.1111/apt.14930.

Related content

EPIGIST: An observational real-life study on patients with metastatic gastrointestinal stromal tumors receiving imatinib

Long-term treatment with plecanatide was safe and tolerable in patients with irritable bowel syndrome with constipation

Irritable Bowel Syndrome (IBS) and Chronic Constipation Long-term treatment with plecanatide was safe and tolerable in patients with irritable bowel syndrome with constipation

Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors following progression with imatinib, sunitinib and regorafenib

Gastrointestinal bleeding in patients with pancreatic cancer: Causes and haemostatic treatments

On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites

Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn's Disease: Results from the Phase 2 Open-Label Extension Study

Clinical activity of ripretinib in patients with advanced gastrointestinal stromal tumor harboring heterogenous KIT/PDGFRA mutations in the phase 3 INVICTUS study

Short and long-term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry